Design, synthesis and mechanistic exploration of anti-plasmodial Indolo[2,3-b]quinoxaline-7-chloroquinoline hybrids.

Aim: The aim of this study is to synthesize indolo[2,3-b]quinoxaline-4-aminoquinoline-based hybrids and evaluate their effectiveness against chloroquine-susceptible (3D7) and resistant (W2) Plasmodium falciparum strains, with expected inhibition of P. falciparum chloroquine resistance transporter (PfCRT) and heme.Methods: The hybrids were synthesized and in vitro evaluated against both susceptible and resistant strains. Molecular docking and studies were conducted to assess the binding affinities for the PfCRT protein. Additionally, heme-inhibition studies using hemin chloride provided valuable insights into the interaction between the ligand and heme. The binding constant (logK) was calculated, providing quantitative details about the strength of this interaction.Conclusion: The synthesized hybrids showed reasonable potency against both P. falciparum strains. The most potent hybrid 10d, with fluorine-substitution exhibited good activity. Molecular docking studies indicated strong binding affinities for the PfCRT protein. Heme inhibition studies further supported the potential of 10d as an effective anti-plasmodial agent.